A placental growth factor variant unable to recognize VEGFR-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization

Autor: De Falco S, Tarallo V, Capasso O, Vesci L, Esposito MT, Pastore L, Orlandi A, Pisano C.

Publikováno v: Cancer research (Chic. Ill., Online) 70 (2010): LB-370.
info:cnr-pdr/source/autori:De Falco S, Tarallo V, Capasso O, Vesci L, Esposito MT, Pastore L, Orlandi A, Pisano C./titolo:A placental growth factor variant unable to recognize VEGFR-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization/doi:/rivista:Cancer research (Chic. Ill., Online)/anno:2010/pagina_da:LB-370/pagina_a:/intervallo_pagine:LB-370/volume:70

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::823feef130e43fbaaf4819d4e621ea49
https://publications.cnr.it/doc/233528

Thymidine Kinase-Mediated Shut Down of Bone Morphogenetic Protein-4 Expression Allows Regulated Bone Production

Autor: Adelaide Greco, Arturo Brunetti, Sara Gargiulo, Maria Teresa Esposito, Teresa Rocco, Donatella Montanaro, Lucio Pastore, Barbara Lombardo, Bruno Cantilena

Publikováno v: Current gene therapy
13 (2013): 202–210.
info:cnr-pdr/source/autori:Lombardo, Barbara; Rocco, Teresa; Esposito, Maria T.; Cantilena, Bruno; Gargiulo, Sara; Greco, Adelaide; Montanaro, Donatella; Brunetti, Arturo; Pastore, Lucio/titolo:Thymidine Kinase-Mediated Shut Down of Bone Morphogenetic Protein-4 Expression Allows Regulated Bone Production/doi:/rivista:Current gene therapy (Print)/anno:2013/pagina_da:202/pagina_a:210/intervallo_pagine:202–210/volume:13

Bone morphogenetic Proteins (BMPs) are growth factors also involved in ossification and chondrogenesis that have generated interest for their efficiency in inducing bone neo-synthesis. BMPs expression in engineered cells has been successful in stimul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3681e7ce93fa63e534bf064aa0446475
https://doi.org/10.2174/1566523211313030005

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.

Autor: Di Mambro A; School of Life and Health Sciences, University of Roehampton, London, UK., Arroyo-Berdugo Y; School of Life and Health Sciences, University of Roehampton, London, UK., Fioretti T; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy., Randles M; Chester Centre for Leukaemia Research, Chester Medical School, University of Chester, Chester, UK., Cozzuto L; Centre Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rajeeve V; Barts Cancer Institute, Queen Mary University of London, London, UK., Cevenini A; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy.; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy., Austin MJ; Barts Cancer Institute, Queen Mary University of London, London, UK., Esposito G; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy.; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy., Ponomarenko J; Centre Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; University Pompeu Fabra (UPF), Barcelona, Spain., Lucas CM; Chester Centre for Leukaemia Research, Chester Medical School, University of Chester, Chester, UK., Cutillas P; Barts Cancer Institute, Queen Mary University of London, London, UK., Gribben J; Barts Cancer Institute, Queen Mary University of London, London, UK., Williams O; Great Ormond Street Institute of Child Health London, UCL, London, UK., Calle Y; School of Life and Health Sciences, University of Roehampton, London, UK., Patel B; Barts Cancer Institute, Queen Mary University of London, London, UK., Esposito MT; School of Life and Health Sciences, University of Roehampton, London, UK. mariateresa.esposito@surrey.ac.uk.; School of Biosciences, University of Surrey, Guildford, UK. mariateresa.esposito@surrey.ac.uk.

Publikováno v: Oncogene [Oncogene] 2023 Dec; Vol. 42 (50), pp. 3670-3683. Date of Electronic Publication: 2023 Oct 27.

A simulation model estimates lifetime health and economic outcomes of screening prediabetes using the 1-h plasma glucose.

Autor: Andellini M; Health Technology Assessment Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Manco M; Research Area for Multifactorial Diseases and Complex Phenotypes. Bambino Gesù Children's Hospital, IRCCS, Via F. Baldelli 38, 00146, Rome, Italy. melania.manco@opbg.net., Esposito MT; Health Technology Assessment Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Tozzi AE; Research Area for Multifactorial Diseases and Complex Phenotypes. Bambino Gesù Children's Hospital, IRCCS, Via F. Baldelli 38, 00146, Rome, Italy., Bergman M; NYU Grossman School of Medicine, NYU Diabetes Prevention Program, Division of Endocrinology, Diabetes, Metabolism, VA New York Harbor Healthcare System, Manhattan Campus, New York, NY, 10010, USA., Ritrovato M; Health Technology Assessment Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Publikováno v: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 9-17. Date of Electronic Publication: 2022 Sep 20.

Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy.

Autor: Roy NK; Case Western Reserve University, Cleveland, OH, United States.; La Jolla Institute for Immunology, San Diego, CA, United States., Tewari D; Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India., Esposito MT; School of Life and Health Science University of Roehampton, Roehampton, United Kingdom.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2022 Aug 30; Vol. 13, pp. 988226. Date of Electronic Publication: 2022 Aug 30 (Print Publication: 2022).